Worth Asset Management LLC bought a new stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 11,770 shares of the semiconductor company’s stock, valued at approximately $1,576,000. Lam Research accounts for about 0.7% of Worth Asset Management LLC’s investment portfolio, making the stock its 29th biggest holding.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. IMG Wealth Management Inc. purchased a new stake in shares of Lam Research during the second quarter worth about $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research during the 2nd quarter valued at approximately $27,000. Sound Income Strategies LLC acquired a new stake in shares of Lam Research during the third quarter worth approximately $41,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the second quarter worth $29,000. Finally, Delos Wealth Advisors LLC acquired a new stake in Lam Research in the second quarter valued at $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Insider Buying and Selling
In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 102,608 shares of company stock worth $14,916,496 in the last quarter. 0.31% of the stock is currently owned by corporate insiders.
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is 22.91%.
Wall Street Analyst Weigh In
Several research firms have weighed in on LRCX. BNP Paribas Exane boosted their target price on shares of Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. HSBC set a $127.00 target price on Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. JPMorgan Chase & Co. increased their price objective on shares of Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Finally, New Street Research lifted their price target on Lam Research from $105.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and a consensus price target of $161.21.
View Our Latest Report on Lam Research
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- Wall Street Stockpicker Names #1 Stock of 2026
- The Best $1 You’ll Spend This Holiday Season
- [URGENT!] SpaceX Going Public! – Pre-IPO Action
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
